Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.
Avantor, Inc. reports developments as a life science tools company supplying mission-critical products and services to life sciences and advanced technology customers through its VWR Distribution & Services and Bioscience & Medtech Products businesses. Recurring updates cover earnings, cash flow, leverage, guidance, segment performance and the company’s Revival transformation program, including VWR brand activity, manufacturing and supply-chain improvements and e-commerce upgrades.
Company news also covers portfolio and infrastructure actions such as Masterflex fluid handling systems, single-use assemblies, peristaltic pumps, J.T. Baker high-purity process chemicals, and expanded microbial and stability testing capabilities for regulated biopharma manufacturing. Governance and management updates include finance leadership changes and appointments tied to bioscience, medtech products and enterprise transformation.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Avantor (NYSE: AVTR) announced it will release its Q1 2023 financial results before the market opens on April 28, 2023. A conference call will follow at 8:00 a.m. Eastern Time to discuss the results. The company is a leading provider of mission-critical products and services across various industries, including biopharma and healthcare. Avantor serves over 300,000 customer locations worldwide, reflecting its extensive reach in research and development.
For more details on the earnings call, visit ir.avantorsciences.com.
Avantor (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technologies sectors, announced management presentations at two major investor conferences. CFO Thomas Szlosek will present at the Raymond James 44th Annual Institutional Investors conference on March 6, 2023, at 1:40 p.m. EST in Orlando, Fla. Meanwhile, President & CEO Michael Stubblefield will engage in a fireside chat at Cowen's 43rd Annual Health Care conference on March 7, 2023, at 9:10 a.m. EST in Boston, Mass. Live audio webcasts will be accessible on Avantor's Investor Relations website, with replays available for 30 days.
Avantor, Inc. (NYSE: AVTR) reported its fourth-quarter and full-year 2022 financial results on February 3, 2023. The company achieved net sales of $1.80 billion for Q4, a 5.9% decline year-over-year, but saw core organic growth of 2.7%. Net income rose to $141.7 million. Full-year net sales reached $7.51 billion, up 1.7%, with core organic growth of 6.0%. Adjusted EBITDA was $1,570.7 million for the year, representing an 11.8% increase. Despite some regional sales decreases, strong performance in bioproduction and margin expansion were highlighted.
Avantor (NYSE: AVTR) and Avantor Foundation announced over $7 million in grants since 2009, focusing on STEM education and healthcare access. In 2022 alone, they donated more than $1 million to 15 organizations and provided over $1.3 million in products for education and disaster relief. The Foundation's recent initiatives included supporting STEM activities for over 2,000 youths in the UK and medical services for 5,000 children in Shanghai, China. Avantor is expanding employee engagement in community service, including matching donations and volunteer time.
Further details will be available in the 2023 Sustainability Report.